Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
AtriCure, Inc. ATRC
$47.86
-$0.3 (-0.63%)
На 18:00, 12 мая 2023
+40.51%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
2282275513.00000000
-
week52high
52.96
-
week52low
32.51
-
Revenue
330379000
-
P/E TTM
-48
-
Beta
1.35294100
-
EPS
-1.05000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 10:59
Описание компании
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 03 авг 2022 г. |
| Needham | Buy | Buy | 03 авг 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Needham | Buy | Buy | 28 июн 2022 г. |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| BTIG | Buy | Buy | 17 окт 2022 г. |
| Needham | Buy | Buy | 02 ноя 2022 г. |
| Canaccord Genuity | Buy | Buy | 02 ноя 2022 г. |
| Needham | Buy | Buy | 19 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Seith Douglas J | A | 79635 | 609 | 30 дек 2022 г. |
| Yount Deborah Lee | A | 17194 | 294 | 30 дек 2022 г. |
| Noznesky Justin J | A | 38414 | 585 | 30 дек 2022 г. |
| CARREL MICHAEL H | D | 528896 | 6000 | 17 ноя 2022 г. |
| Doraiswamy Vinayak | D | 19406 | 4983 | 15 сент 2022 г. |
| WHITE ROBERT S. | A | 20000 | 15000 | 31 авг 2022 г. |
| WHITE ROBERT S. | A | 55799 | 15000 | 31 авг 2022 г. |
| Wirick Angela L | D | 70846 | 5191 | 06 авг 2022 г. |
| CARREL MICHAEL H | A | 534896 | 350 | 30 июн 2022 г. |
| Privitera Salvatore | A | 60834 | 350 | 30 июн 2022 г. |
Новостная лента
AtriCure, Inc. (ATRC) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 мая 2023 г. в 21:40
AtriCure, Inc. (NASDAQ:ATRC ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Marissa Bych – Vice President-Gilmartin Group Mike Carrel – President and Chief Executive Officer Angie Wirick – Chief Financial Officer Conference Call Participants Matthew O'Brien – Piper Sandler Marie Thibault – BTIG John McAulay – Stifel Joseph Conway – Needham Suraj Kalia – Oppenheimer Operator Good afternoon, and welcome to AtriCure's First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
02 мая 2023 г. в 19:09
AtriCure (ATRC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.33 per share a year ago.
AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last?
Zacks Investment Research
27 мар 2023 г. в 09:57
AtriCure (ATRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AtriCure, Inc. (ATRC) Q4 2022 Earnings Call Transcript
Seeking Alpha
21 февр 2023 г. в 22:47
AtriCure, Inc. (NASDAQ:ATRC ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Robbie Marcus - J.P. Morgan Bill Plovanic - Canaccord Marie Thibault - BTIG Mike Matson - Needham Suraj Kalia - Oppenheimer Rick Wise - Stifel Operator Good afternoon, and welcome to AtriCure's Q4 2022 Earnings Conference Call.
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
21 февр 2023 г. в 18:49
AtriCure (ATRC) delivered earnings and revenue surprises of 50% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?